ICIs May Support Nonsurgical dMMR Cancer Care - Summary - MDSpire

ICIs May Support Nonsurgical dMMR Cancer Care

More than half of evaluable patients with locoregional disease achieved complete response following immune checkpoint inhibitor therapy.

  • By

  • Andrea Surnit

  • July 21, 2026

  • 3 min

Share

Original Source(s)

ICIs May Support Nonsurgical dMMR Cancer Care

  • by Andrea Surnit

  • July 21, 2026

Related Content

Rapid AST Speeds Care, Not Outcomes

Faster antibiotic optimization may still support use of rapid testing, particularly when paired with stewardship.

Online Program Eases Pediatric Trauma Stress

Randomized trial evaluated therapist-assisted intervention among pediatric patients with persistent symptoms 1 month following trauma

FDA Expands Test for Gastric and Esophageal Cancers

According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.